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Schistosomiasis is a parasitic disease that affects over 240 million
people globally. To improve population-level disease control,
there is growing interest in adding chemical-based snail control
interventions to interrupt the lifecycle of Schistosoma in its snail
host to reduce parasite transmission. However, this approach is
not widely implemented, and given environmental concerns, the
optimal conditions for when snail control is appropriate are un-
clear. We assessed the potential impact and cost-effectiveness of
various snail control strategies. We extended previously published
dynamic, age-structured transmission and cost-effectiveness models
to simulate mass drug administration (MDA) and focal snail control
interventions against Schistosoma haematobium across a range of
low-prevalence (5–20%) and high-prevalence (25–50%) rural Kenyan
communities. We simulated strategies over a 10-year period of MDA
targeting school children or entire communities, snail control, and
combined strategies. Wemeasured incremental cost-effectiveness in
2016 US dollars per disability-adjusted life year and defined a
strategy as optimally cost-effective when maximizing health gains
(averted disability-adjusted life years) with an incremental cost-
effectiveness below a Kenya-specific economic threshold. In both
low- and high-prevalence settings, community-wide MDA with
additional snail control reduced total disability by an additional
40% compared with school-based MDA alone. The optimally cost-
effective scenario included the addition of snail control to MDA in
over 95% of simulations. These results support inclusion of snail
control in global guidelines and national schistosomiasis control
strategies for optimal disease control, especially in settings with
high prevalence, “hot spots” of transmission, and noncompli-
ance to MDA.
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Schistosomiasis is a disease caused by parasitic worms of thegenus Schistosoma that affects over 240 million people in
low- and middle-income countries (1, 2). Over the past decade,
the global strategy for schistosomiasis has focused on control of
disease morbidity through scale up of targeted mass drug ad-
ministration (MDA), also known as preventive chemotherapy, to
school-aged children using empiric praziquantel treatment of
populations in endemic areas (3, 4). While the approach of re-
peated MDA with a goal of 75% coverage in school-aged children
has resulted in some success in reducing long-term morbidities,
transmission is not interrupted, children typically suffer from
high rates of reinfection, and the broader community (preschool
children, adolescents, and adult populations) remains affected
by schistosomiasis (5–7). There is now growing interest in im-
proving morbidity control through reduction or elimination of
schistosomiasis (8).
In addition to MDA, one complementary approach is the local
control of intermediate host snails to interrupt the nonhuman
phase of the Schistosoma lifecycle (8–10). Whereas snail control
is not a focus of the current global strategy, growing evidence
suggests that it could play an effective role in epidemic control,
especially in areas of high transmission (e.g., hot spots) (8–14). In
a recent meta-analysis of observational data, snail control (mol-
lusciding) through chemical-based method (e.g., niclosamide) was
found to be effective in schistosomiasis control, with measured
reductions in both prevalence and incidence of schistosomiasis
(11). This conclusion was further supported by another study
that found that a country-level control strategy with a focus on
snail control had larger reductions in infection prevalence than
countries without snail control (13). Snail control has also
notably achieved widespread success in schistosomiasis con-
trol and elimination campaigns in many parts of Asia (12).
Furthermore, the WHO has recently published new guidelines
for field application methods for chemical-based snail control,
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which underscore the renewed interest in the use of snail
control in some settings (10).
While there is growing support for inclusion of snail control
within national strategies for schistosomiasis, the conditions
under which employment of this strategy is beneficial and fea-
sible are unclear. Chemical-based methods for snail control (e.g.,
niclosamide) are costly, are labor intensive, and do not prevent
repopulation of snails after treatment (10, 12). Furthermore,
chemical-based snail control can be toxic within the environ-
ment, which may lead to unintended ecological consequences
(12). With these considerations in mind, additional guidance is
needed that define the settings and conditions under which snail
control could be beneficial. The key policy-relevant questions in-
clude the comparative cost-effectiveness of snail control used
alone or when combined with MDA, how the decision to use
snail control varies in different burden settings, and the impact of
varying snail control frequencies. To address these questions, we
modeled the cost-effectiveness of MDA, snail control (focal
chemical-based snail control), and combined strategies against
schistosomiasis using data from low- and high-burden communities
in rural Kenya.
Results
Baseline Burden of Disease in Kenyan Communities. In the low-
burden 5,000-person communities with an overall mean preva-
lence of 12% (44% of these were heavy infection), we estimated
a total of 172 disability-adjusted life years (DALYs) over 10 y
without intervention (SI Appendix, Table S1). In the high-burden
5,000-person communities with mean prevalence of 38% (48%
of these were heavy infections), we estimated a total of 550
DALYs over 10 y without intervention. Following the WHO
guidelines (3, 4, 15), both settings would receive MDA targeting
school-aged children.
Effectiveness and Cost-Effectiveness of MDA, Snail Control, and
Combined Strategies. We found that expanded MDA (community-
wide compared with school-based), more frequent intervention,
and the additional of snail control would substantially reduce in-
fection prevalence and infection intensity beyond the effect of the
standard WHO intervention of school-based MDA alone (Fig. 1
and SI Appendix, Fig. S1). We found that use of snail control in-
terventions alone projected prevalence reductions similar but less
than those achieved by school-based MDA alone. Community-wide
MDA provided greater prevalence reductions than school-based
MDA or snail control alone. The more aggressive combined
strategies (community-wide MDA and snail control) were the most
effective to reduce both prevalence and infection intensity. Notably,
there was a nonlinearity in effectiveness (averted DALYs) with
more aggressive strategies, where additional intervention yielded
smaller gains in effectiveness (Fig. 2).
Under the base case scenario with 10% systematic non-
compliance (SI Appendix, Table S1), we found that, in low-burden
settings, semiannual school-based MDA with semiannual snail
control was highly cost-effective [incremental cost-effectiveness
ratio (ICER): $904 US per DALY], and annual community-
wide MDA with semiannual snail control was bordering on
being highly cost-effective (ICER: $1,531 US per DALY). In
high-burden settings, annual community-wide MDA with semi-
annual snail control was highly cost-effective (ICER: $588 US
per DALY), and semiannual community-wide MDA with semi-
annual snail control was also highly cost-effective (ICER: $1,213
US per DALY). The cost-effectiveness efficiency frontier showed
the incremental costs and averted disability of key strategies
(Fig. 2). The addition of snail control had a lower ICER (more
cost-effective) in the high-burden setting, suggesting the pri-
oritization of snail control in high-prevalence regions rather
than lower-prevalence areas.
Sensitivity, Scenario, and Uncertainty Analyses. We performed one-
way sensitivity analyses for our primary cost-effective strategies
and found that transmission uncertainty (which varied environ-
mental and behavioral conditions and influenced snail control
effectiveness), MDA delivery cost, schistosomiasis-associated dis-
ability weights, environmental conditions (e.g., snail and human
density, “hot spot” populations), and systematic noncompliance
were influential model parameters (Fig. 3). In scenario analysis,
we simulated spatial connectivity with neighboring environments
or hot spots by introducing a constant migration of snails and
infected humans into the environment and a proportion of the
force of infection from an external source; we found these
factors to improve the cost-effectiveness (lower ICER) of key
strategies (Fig. 3). In scenario analyses, we found that addition of
snail control was most cost-effective (lower ICER) in settings
with higher disease burden and higher snail and human population
Fig. 1. Effectiveness of selected MDA, snail control, and combined inter-
ventions for schistosomiasis in low- and high-burden Kenyan communities.
We simulated interventions of MDA, snail control, and combined ap-
proaches in an age-stratified population of preschool-aged children, school-
aged children, and adults in (A) low-prevalence Kenyan communities and (B)
high-prevalence Kenyan communities with 75% coverage for MDA. The
figure displays selected interventions for visualization purposes; plots for all
tested interventions are available in SI Appendix.
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density (Figs. 2 and 3 and SI Appendix, Tables S2 and S3). We
repeated our base case analysis with differing levels of systematic
noncompliance for participation in MDA. We found that increased
systematic noncompliance improved the cost-effectiveness of add-
ing snail control in many settings, while reducing the impact and
cost-effectiveness of MDA; however, the overall cost-effectiveness
of combined strategies in systematically noncompliant populations
were lower (higher ICER), since MDA strategies had less impact.
We varied intervention effectiveness (e.g., snail control, praziquantel
efficacy for worm reduction), which often improved the cost-
effectiveness (lower ICER) of more aggressive strategies, since
the incremental benefit became larger when considering less
effective interventions. We characterized the programmatic pa-
rameter values where these primary strategies were no longer
robust (SI Appendix).
In the uncertainty analysis (SI Appendix, Figs. S2 and S3), for
low-burden settings, we found that school-based MDA with snail
control was the optimal cost-effective strategy in 50% of simula-
tions, while community-wide MDA with snail control was optimal
in 46% (Table 1). In high-prevalence settings, community-wide
MDA with snail control was the optimal cost-effective strategy
in 95% of simulations. In 99% of simulations, the optimally cost-
effective scenario included snail control; over 97% included both
snail control and MDA.
In low-prevalence communities, we found the strategy of
semiannual school-based MDA with semiannual snail control to
be highly cost-effective in 67% of the simulations and optimally
cost-effective in 30% [ICER, 95% uncertainty interval (95% UI):
$351–$3,884 US per DALY]; annual community-wide MDA with
semiannual snail control was highly cost-effective in 43% of the
simulations and optimally cost-effective in 42% (ICER, 95% UI:
$495–$4,867 US per DALY). In high-prevalence settings, we found
the strategy of semiannual community-wide MDA with semiannual
snail control to be highly cost-effective in 71% of simulations and
optimally cost-effective in 71% (ICER, 95% UI: $511–$2,773 US
per DALY).
Discussion
In this modeling study, we found that inclusion of snail control
alongside MDA is a highly cost-effective strategy for targeting
schistosomiasis. In low-burden settings, we estimated that
school-based MDA with snail control and possibly, community-
wide MDA with snail control could be highly cost-effective. In
high-burden communities, which may be recalcitrant to school-
based MDA alone, community-wide MDA with snail control was
robust in being highly cost-effective. In over 95% of simulations,
the optimally cost-effective strategy included snail control. Im-
portantly, setting-specific differences could inform implementa-
tion of more refined snail control strategies (10, 11). Overall,
these findings support the inclusion of snail control in global
guidelines and national schistosomiasis control strategies to
achieve optimal disease control, especially in settings with high-
disease burden, hot spots of transmission, and high systematic
noncompliance to MDA.
Over the past decade, MDA programs have scaled up across
many low- and middle-income countries for control of schistoso-
miasis, and great progress has been made to decrease the burden
of this helminthiasis (16). The primary public health strategy has
been MDA targeting school-aged children, and while this strategy
has reduced disease burden in this demographic group, the ap-
proach of school-based MDA often results in reinfection, does not
address broader age groups, and has not led to elimination of
transmission (5–7). Recent modeling and health economic studies
have found that expanded community-wide MDA that includes
preschool-aged children, adolescents, and adults would better
reduce overall disease burden and reinfection at a rate greater
than that for school-based control alone and would be highly cost-
effective (17–20). As the global strategy changes and broader revi-
sions of guidelines are considered, complementary strategies are
important to evaluate. For these reasons, we tested the projected
cost-effectiveness of snail control implemented alongside MDA
strategies to understand the optimal epidemiologic conditions for
implementation to support national and global strategies. Impor-
tantly, while MDA strategies aim to reduce infection prevalence and
Fig. 2. Cost-effectiveness efficiency frontier for selected MDA, snail control,
and combined interventions for schistosomiasis in low- and high-burden
Kenyan communities. We computed the costs (US dollars) and averted
DALYs for nondominated interventions of MDA, snail control, and combined
approaches in the (A) low-prevalence Kenyan communities and (B) high-
prevalence Kenyan communities. Dominated strategies are not shown, and
full results are available in SI Appendix, Table S1. The cost-effectiveness of each
strategy is measured with the ICER. The ICER is computed in reference with the
next best strategy in terms of averted DALYs (corresponding to the strategy
directly to the left on the frontier). The ICER is computed as the difference in
cost divided by the difference in DALYs, which is shown as the slope between
strategies. A steeper slope indicates a lower ICER (more cost-effective), while a
flatter slope suggests a higher ICER (less cost-effective). Notably, there is strong
nonlinearity in effectiveness (averted DALYs), whereby additional intervention
yields smaller gains and high ICER. CWT, community-wide treatment with
MDA; SBT, school-based treatment with MDA; SC, snail control.
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avert disability by treating human infections and reducing trans-
mission, snail control works solely by reducing future transmission.
Using data from low- and high-prevalence settings in rural
Kenya, we generated a range of hypothetical communities for low-
and high-prevalence conditions that shared similar baseline disease
burden but had varied snail environment and behavioral condi-
tions. We found that addition of snail control alongside MDA was
highly cost-effective in almost all simulations. These results suggest
a need for addition of snail control with inclusion of expanded
community-wide MDA in many settings, especially high-burden
settings, where there are higher rates of reinfection and disease
burden cannot be reduced without additional “vector control.”
Overall, the study conclusions align with a past analysis that ex-
amined costs and snail mortality in China, which found that focal
snail control can be an efficient strategy for schistosomiasis control
(21). These main study findings suggest that the current global
strategy of school-based MDA alone is too restrictive for optimal
morbidity control and support the recent publication of the WHO
guidelines on field use of snail control in hot spot regions and
expanded community-wide MDA in some settings (10).
The cost-effectiveness of adding snail control alongside
community-wide MDA was robust in high-burden settings but
less so in some low-burden settings, where semiannual school-
based MDA with snail control may be sufficient. To assess the
predicting factors, we performed sensitivity and uncertainty
analyses that tested a broad range of plausible values for model
inputs across Schistosoma epidemiology, cost, and intervention
parameters, which may improve the generalizability of our study
findings to other settings. There is likely a wide range of setting-
specific responses to snail control in terms of effectiveness and
coverage, and therefore, we provided sensitivity analyses to char-
acterize the distribution of possible cost-effectiveness results. In-
terestingly, sensitivity analyses found improved cost-effectiveness
for more aggressive strategies (e.g., frequent community-wide
MDA with snail control) when snail control and praziquantel
were less effective, since these strategies yielded larger incremental
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Fig. 3. One-way sensitivity analysis of key model parameters. This analysis tested the effect of changing a single model input on the ICER of the highly cost-
effective interventions from the primary analysis: (A) semiannual school-based MDA with semiannual snail control in low-prevalence settings, (B) annual
community-wide MDA with semiannual snail control in low-prevalence settings, (C) annual community-wide MDA with semiannual snail control in high-
prevalence settings, and (D) semiannual community-wide MDA with semiannual snail control in high-prevalence settings. We varied values for model inputs
related to transmission dynamics, costs, and intervention effectiveness, including sampling from the posterior distribution generated during model cali-
bration, which affects transmission projections and snail control effectiveness. The horizontal axis represents the ICER values (US dollars per DALY averted),
while the vertical axis includes tested parameters with respective ranges of values. A lower ICER can be interpreted as a more cost-effective intervention, and
we considered all strategies left of the $1,377 US per DALY averted to be highly cost-effective, although the full axis is provided to relax reliance on a single
threshold. *The 95% credible interval of the transmission projection incorporates the full range of values for the effectiveness snail control and in some cases,
was dominated by extension in the lower ranges. **Snail control effectiveness on schistosomiasis was calibrated based on empirical data and is a function of
multiple parameters (including snail control efficacy); the lower MDA coverage range still simulated 75% coverage for school-based MDA.
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benefits and suffered less from diminishing returns with more
aggressive strategies. Importantly, setting-specific analyses that
incorporate local data (e.g., epidemiologic inputs, willingness-to-pay
threshold) can allow for a more tailored cost-effectiveness analysis.
In these cases, N.C.L. may be contacted to create context-specific
findings on cost-effectiveness of snail control and MDA.
Notably, increasing levels of systematic noncompliance to
MDA and hot spots of transmission improved the cost-effectiveness
of adding snail control strategies. Systematic noncompliance has
been documented in many MDA programs (22) and reduces the
impact of MDA on transmission, whereas snail control depends
less on sustained community participation. Systematic noncom-
pliance may be particularly high when sensitization is not included
before MDA campaigns and may also vary by Schistosoma spp.
depending on clinical presentation (e.g., hematuria from Schisto-
soma haematobium). We simulated hot spots and potential spatial
connectivity with neighboring communities and found more ag-
gressive strategies that combined MDA and snail control to be
more cost-effective in these locations. This is likely because the
incremental benefit of more aggressive interventions (e.g., commu-
nity MDA, frequent snail control) relative to other less intensive
strategies is increased in hot spots because of the high force of
infection and reinfection.
We focused on evaluating the addition of chemical-based
methods for snail control because of its historical use and greater
strength of observational evidence for its effectiveness (11, 23).
However, other forms of snail control may be relevant, including
biological control through introduction of competitor snail spe-
cies or prawns that feed on host snail populations (24–27). In our
analysis, we did not account for potential unintended environ-
mental or ecological consequences of chemical-based snail con-
trol and their associated cost, which should be considered during
intervention planning, although ecological costs from snail con-
trol could be conceptualized as a higher cost of the intervention
as examined in the sensitivity analysis. Evidence suggests that the
commonly used chemical (niclosamide) has minimal risk to hu-
mans, livestock, poultry, plants, and environment when applied
appropriately, especially given its short half-life in the water;
however, the chemical is directly toxic to fish and amphibians
(e.g., frogs), which could have larger ecological ramifications (9,
10, 28). For this reason, snail control should be limited to regions
with known schistosomiasis disease burden, use recommended
doses to mitigate ecological consequences, and be implemented
in discussion with the local community to balance public health
needs and environmental concerns (9, 10). Furthermore, focal snail
control strategies modeled in this study likely have reduced eco-
logical impact compared with the alternative of blanket application.
The study results should be interpreted within the context of
its limitations, model assumptions, and available data. There is
uncertainty around many aspects of cost, intervention effective-
ness, and disability for schistosomiasis. We addressed this by
constructing a 95% UI that provided a range of plausible out-
comes for cost-effectiveness, which was driven by both un-
certainty and setting-specific differences. There is debate around
the measurement of disability for schistosomiasis (29, 30). We
used conservative estimates that focus on acute morbidities that
are reversible through intervention (20, 31), although this ap-
proach may underestimate the chronic sequelae from long-term
infection and exposure to Schistosoma eggs (29, 30, 32). Future
work should include modeling “cumulative person-level worm-
years” to account for reductions in chronic morbidity from sus-
tained public health interventions, which would provide increased
cost-effectiveness for an intervention over time (33, 34). While the
effectiveness estimates for snail control were informed by a recent
meta-analysis of observational studies (11), there are uncertainties
and setting-specific differences (e.g., number of water bodies,
distance to travel to water, and volume of water) that will affect
both the costs and benefits of snail control. To address this, we
tested a range of possible costs and effectiveness estimates in-
formed by data from observational studies and found our results
to be broadly robust. Importantly, structural and parameter as-
sumptions can influence an intervention’s impact on transmission
(35). We made a number of simplifying assumptions as per common
modeling practice: we modeled the effect of treatment to be in-
stantaneous; we assumed perfect mixing within each subpopulation;
we did not account for the effect of transmission superspreaders; we
modeled transmission dynamics, including that infection of snails
(force of infection) saturated with human infectivity, which can have
significant affect on control outcomes; and we explicitly accounted
for the effect of snail density on transmission (19, 36–38). We as-
sumed stationary transmission environment and snail biology without
seasonality. In reality, the snail component can vary from “near
stationary” (river, lakeshore, irrigation scheme) to highly dynamic
with dramatic changes of snail abundance (seasonal ponds). Sea-
sonality could potentially be leveraged for more efficient design of
control interventions, and future work should address these topics by
utilizing resource-driven models of snail population biology and
control (39, 40). The model does not include a maintenance cost for
snails or crowding effect from snail density, although these snail
resource effects on overall transmission (mediated by snail cer-
cariae production) are likely to be minimal based on empirical
data in realistic environmental conditions (11). We did not model
Table 1. Proportion of simulations from multiway uncertainty
analysis, where the control strategy is the optimal
cost-effective strategy
MDA Snail control
Low-prevalence
communities
High-prevalence
communities
None None 0 0
None Annual 0 0
None Semiannual 2.8 0
SBT annual None 0 0
SBT semiannual None 0 0
SBT annual Annual 0.1 0
SBT annual Semiannual 20.6 0
SBT semiannual Annual 0 0
SBT semiannual Semiannual 30.2 5.1
CWT, annual None 0 0
CWT semiannual None 0.1 0.3
CWT annual Annual 3.5 0.4
CWT annual Semiannual 42 23.5
CWT semiannual Annual 0 0.3
CWT semiannual Semiannual 0.7 70.5
The strategy that is the optimal cost-effective choice has the highest
averted DALYs, with an ICER below the threshold of $1,377 US per DALY.
CWT, community-wide treatment with MDA; SBT, school-based treatment
with MDA.
Table 2. Baseline cohort characteristics
Parameter Base case value Source
Preschool children, % 18 —*
School-aged children, % 28 —*
Adults, % 54 —*
Women, % 50 —*
Community population 5,000 Assumption
Adult male mean Hb (SD), g/L 134 (19) Refs. 19 and 20
Adult female mean Hb (SD), g/L 111 (16) Refs. 19 and 20
Child mean Hb (SD), g/L 112 (15) Refs. 19 and 20
Systematic noncompliance, % 10 Ref. 22
Hb, hemoglobin.
*Data are from cross-sectional surveys in Kenyan communities (42, 43).
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any resistance to praziquantel or to chemical-based snail control
because of limited evidence for their existence, although rigorous
monitoring for efficacy would be necessary as these interventions
are scaled up and treatment pressure is increased. Finally, future
work should evaluate the effects of supplemental water, sanitation,
and hygiene interventions, which are likely to prove necessary to
fully eliminate transmission, and include development of an in-
teractive tool for programmatic decision-making that incorporates
model-based results for schistosomiasis programming alongside
other diseases and health programs.
In summary, our study results support the inclusion of snail
control in global and national strategies against schistosomia-
sis, especially in high-burden settings, hot spot regions, or areas
with systematic noncompliance to MDA, since snail control
can mitigate risk of reinfection in endemic ecosystems and
does so irrespective of person-level compliance. The analysis
also supports previous work that finds that community-wide
MDA is highly cost-effective relative to school-based MDA
alone. The disparity between current WHO recommendations
for school-based MDA alone and the cost-effectiveness of ex-
panded community-wide MDA with addition of snail control in
many settings supports calls to consider strengthened guidelines
and strategy to reduce the global disease burden of schistosomiasis.
Materials and Methods
Methods Overview. We adapted a mathematical model for transmission of S.
haematobium and modeled cost-effectiveness of various interventions over a
10-y period in 5,000-person communities (18, 19, 37, 41). We chose the time
horizon based on the duration necessary to capture long-term differences
between strategies and timelines for country-level programmatic planning.
We calibrated the model to age-structured empirical data on prevalence and
mean infection intensity (measured in eggs per 10 mL of urine) from a sim-
ulated set of low-burden (5–20% prevalence; mean: 12%) and high-burden
(25–50% prevalence; mean: 38%) rural settings in the southeastern coastal
regions of Kenya to model different epidemiologic settings (37, 41–43) (Tables
2 and 3). Notably, we simulated many sets of hypothetical communities for
both low- and high-prevalence settings, which shared similar baseline disease
burden but had varying snail environment and behavioral conditions. We
simulated school-based and community-based MDA with praziquantel, focal
chemical-based snail control using niclosamide (an intervention that concen-
trates on known freshwater bodies where transmission may be occurring),
and a combined approach that included both strategies. We tested both
annual and semiannual (twice per year) interventions.
Model of Helminth Transmission and Interventions. We adapted the dynamic,
demographically structured, and deterministic stratified worm burdenmodel
to simulate transmission of S. haematobium (37, 41) (SI Appendix). This
compartmental model stratified a human population by age group and
worm burden and dynamically tracked each worm stratum over time to
represent changing prevalence and infection intensity. This transmission
structure included many aspects of the biology of transmission, including
human release of eggs from urine into the environment, the snail in-
termediate host that allows for maturation of the parasite in the environ-
ment, and eventual infection of humans through direct contact with fresh
water. We included important epidemiologic factors and intrahost biology,
such as worm mating, age-specific mortality, and random overdispersed egg
release by infected human hosts (38, 44, 45). The local snail community was
explicitly modeled and coupled to the human population, which allowed for
simulation of interventions for both MDA (affecting humans) and snail
control (affecting the snail population). We assumed a 10% prevalence of
systematic noncompliance to MDA in the base case analysis to account for a
proportion of the population that was repeatedly missed by treatment based
on estimates from the literature (22). The transmission model was calibrated
with a Bayesian Monte Carlo procedure to estimate a joint distribution of
Table 3. Baseline cohort epidemiology
Parameter
Mean
prevalence, %
Mean
prevalence, heavy
intensity, %
Kenyan communities, low prevalence
Preschool-aged child prevalence 4.5 1.8
School-aged child prevalence 20.6 10.0
Adult prevalence 10.6 4.2
Overall 12.3 5.4
Kenyan communities, high prevalence
Preschool-aged child prevalence 16.4 7.8
School-aged child prevalence 69.0 40.1
Adult prevalence 28.5 10.5
Overall 37.7 18
Data are from cross-sectional surveys in Kenyan communities (41, 42).
Table 4. Estimated intervention costs and disability of schistosomiasis
Category Description Units Quantity Cost per unit, US$
MDA costs (3, 19, 47, 48)
Drug Praziquantel Per person —* 0.21
Delivery School-based delivery Per delivery —* 0.50
Delivery Community-based delivery Per delivery —* 1.50
Total cost, school-based program Per person — 0.71
Total cost, community-based program Per person — 1.71
Snail control costs (49–51)
Capital costs†
Equipment Spraying unit, Hudson Per unit 1 400
Equipment Spraying unit, Petrol Per unit 1 300
Equipment Protective clothing Per team 4 50
Equipment GPS Per unit 1 200
Equipment pH meter Per unit 1 250
Variable costs
Snail control chemical Niclosamide chemical Per kilogram 3 40
Personnel Personal compensation Per day 5 25
Transportation Transportation (car, fuel) Per day 1 100
Equipment Laboratory consumables Per day 1 25
Total cost, snail control‡ Per community — 379.43
*Quantity is computed based on age targeting and coverage.
†Capital costs are annualized using an equivalent annual cost over 3 y at 3% discounting, with 65 working days per year (number of
weekdays during the 3 rainy months of the year).
‡Snail control costs are estimated for intervention in a small (5,000-person) community. This estimation includes both capital and
variable costs. It assumes that one team can treat one community per day with 3 kg of chemical snail control per community.
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model parameters using observed cross-sectional surveys on prevalence and
infection intensity in children and adults from rural Kenyan communities
(37, 41–43) (SI Appendix).
We modeled MDA as an instantaneous reduction in human worm burden
after treatment with praziquantel using data from clinical trials on drug
efficacy (46) and similarly assumed an immediate reduction in snail density
after focal chemical snail control (11) (SI Appendix). There is substantial
heterogeneity in the observed effectiveness of snail control (measured in
relative incidence reduction and prevalence reduction in the human pop-
ulation) (11). We modeled the effect of snail control using a combination of
model parameters to generate a distribution for the effect size of snail
control for the base case analysis (SI Appendix). We calibrated this distri-
bution to broadly align with the range of observed prevalence and incidence
reductions after snail control interventions using data from a recent meta-
analysis (11) (SI Appendix, Fig. A5).
Cost-Effectiveness Model and Assumptions. We adapted a cost-effectiveness
model that included cost and disability estimates for implementation of
various MDA and snail control strategies against schistosomiasis (19, 20). We
estimated direct programmatic costs (2016 US dollars) from the perspective of a
national disease control program. We estimated costs for MDA and snail
control based on published literature and programmatic data from the Schis-
tosomiasis Consortium for Operational Research and Evaluation (SCORE) Trial
(3, 19, 47–51) (SI Appendix). The cost of MDA was estimated as the per-
person price of drugs (not assumed to be donated) and delivery (e.g.,
staff salaries, transportation, and administrative fees) for either school- or
community-based programs (3, 19, 47, 48). We estimated a per-community
(e.g., small 5,000-person community) cost for snail control that included
both capital cost of equipment and variable costs per community (i.e.,
chemical for snail control, staff salaries, transportation), which was informed
by experience from historical literature and the recent SCORE Trial that
implemented chemical-based snail control (49–52). We annualized equipment
over the expected lifetime of utility and work schedule. The estimated costs
are presented in Table 4.
We modeled disability with the DALY using published sequelae and
disability weights (which measures disease disability for 1 y of a human life,
where zero is perfect health and one is death) following convention for cost-
effectiveness analyses (20, 53, 54). We distributed the infection-associated
disability weights based on observed egg counts in urine as an indicator
of infection intensity using the WHO thresholds for egg counts (>50 eggs
per 10 mL of urine as a heavy infection) and for anemia (Table 5). The
cost-effectiveness of a strategy was computed as the ICER (US dollars per
DALY averted), which is a relative ratio that compares two strategies and
is the difference in cost divided by the difference in DALYs. The computation
procedure for the ICER ranks all strategies by increasing health gains
(averted DALYs), and each strategy’s ICER is then computed in reference to
the next most effective strategy (defined as the control intervention with
next highest averted DALYs that is nondominated on the cost-effectiveness
frontier). This incremental calculation using the “next best comparator”
(rather than a single comparator) follows convention, accounts for all
available and mutually exclusive choices, and is necessary to maximize the
objective function for cost-effectiveness. We used a base case strategy of
no intervention. Strategies were defined as highly cost-effective if the ICER
was below a willingness-to-pay threshold of the gross domestic product
(GDP) per capita ($1,377 US per DALY for Kenya) following common
practice, although we tested alternative values to relax reliance on a single
threshold. We defined the optimal cost-effective strategy as the choice
with highest averted DALYs and ICER below the willingness-to-pay
threshold. For further conceptualization of the willingness-to-pay threshold
used to interpret the ICER, some common global health interventions and
their associated ICERs include malaria bed nets ($5–$17 US per DALY), child-
hood vaccination ($10–$30 US per DALY), antiretroviral treatment ($300–$500
US per DALY), improvements in water and sanitation ($1,100–$15,000 US per
DALY), and latent TB treatment ($4,000–$25,000 US per DALY) (55). We de-
fined strategies as strictly dominated when they had lower effectiveness
and higher cost than another choice and dominated by extension when the
strategy was less effective and had a higher ICER relative to another choice.
We computed the cost-effectiveness efficiency frontier, which plots costs
and effectiveness (averted DALYs) of all strategies to understand compar-
ison and tradeoff of cost and health gains among many control strategies to
support decision-making, especially in cases where resources may be limited.
On the frontier, the optimal strategy maximized averted DALYs while main-
taining an ICER (slope of line between strategy and next best comparator;
measured in US dollars per averted DALYs) below a defined willingness-to-pay
threshold. Total costs and disability were discounted at 3% annually, and
undiscounted results were also calculated (56) (SI Appendix).
Sensitivity, Scenario, and Uncertainty Analyses. We tested the robustness of
our primary study findings with one-way sensitivity andmultiway uncertainty
analyses that varied key model parameters across a range of possible values.
We conducted one-way sensitivity analyses on inputs related to Schistosoma
natural history, transmission, environmental conditions (e.g., snail population,
spatial connectivity), intervention effectiveness, compliance (MDA and snail
control), and cost. We accounted for uncertainty in disease transmission by
sampling from the posterior distribution, which provided multiple sets of
fitted transmission parameters to create a range of model projections, and
applied this in the one-way and multiway sensitivity analyses. This sampling
process also captured heterogeneity in snail control effectiveness by creating
a distribution for the effectiveness of snail control (measured in relative in-
cidence and prevalence reduction), which helped estimate the robustness of
the model conclusions for varying effectiveness levels for snail control (full
distribution of effect size for snail control is in SI Appendix, Fig. A5). We also
explicitly varied the effectiveness of snail control, which could also be con-
ceptualized as regional coverage. To understand the impact of environmental
differences, we incorporated snail migration and a proportion of the force of
infection from external human sources to simulate spatial connectivity with
neighboring environments, which could represent hot spot communities. We
also included a formal characterization of costing values where primary
findings are no longer robust and alternative assumptions on systematic
noncompliance to MDA (22). Scenario analyses of key combination of model
inputs were also computed.
We performed a multiway uncertainty analysis on helminth transmission
and cost-effectiveness, where we varied many model inputs simultaneously
to generate a 95% UI. In these analyses, we sampled from the posterior
distribution of the transmission parameters to propagate uncertainty
in disease transmission and also varied the model inputs for the cost-
effectiveness analysis, including the school-based and community-wide
MDA cost, snail control cost, disability weights, and noncompliance (SI Ap-
pendix, Table S4). In each uncertainty analysis simulation, we constructed a
cost-effectiveness frontier and computed the ICER of our key strategies
relative to the next best option in terms of averted disability, and we
reported the proportion of simulations where each strategy was optimally
cost-effective. The data and model code are available online (57). This study
was not human subject research and relied on published data.
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Table 5. Estimated intervention costs and disability of schistosomiasis
Source Sequelae Infection intensity Disability weights Refs.
Disability structure
Schistosoma infection Infection Light 0.014 19, 20, 29, 48, 53, 54
Schistosoma infection Infection Heavy 0.05 19, 20, 29, 48, 53, 54
Anemia Mild anemia All 0.0041 19, 20, 53
Anemia Moderate anemia All 0.0056 19, 20, 53
Anemia Severe anemia All 0.1615 19, 20, 53
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